ELISA Kit for Low Density Lipoprotein Receptor Related Protein 1 (LRP1)

CD91; LRP; A2MR; APOER; APR; TGFBR5; Alpha-2-Macroglobulin Receptor; Prolow-density lipoprotein receptor-related protein 1; Apolipoprotein E receptor

Specificity

This assay has high sensitivity and excellent specificity for detection of Low Density Lipoprotein Receptor Related Protein 1 (LRP1).
No significant cross-reactivity or interference between Low Density Lipoprotein Receptor Related Protein 1 (LRP1) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Low Density Lipoprotein Receptor Related Protein 1 (LRP1) and the recovery rates were calculated by comparing the measured value to the expected amount of Low Density Lipoprotein Receptor Related Protein 1 (LRP1) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 79-104 99
EDTA plasma(n=5) 85-103 101
heparin plasma(n=5) 94-101 97

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Low Density Lipoprotein Receptor Related Protein 1 (LRP1) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Low Density Lipoprotein Receptor Related Protein 1 (LRP1) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Low Density Lipoprotein Receptor Related Protein 1 (LRP1) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 79-90% 80-95% 82-92% 85-93%
EDTA plasma(n=5) 84-101% 98-105% 97-105% 78-104%
heparin plasma(n=5) 87-95% 80-94% 92-101% 95-102%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
European Journal of Vascular and Endovascular Surgery Plasma Low-density Lipoprotein Receptor-related Protein 1 Concentration is not Associated with Human Abdominal Aortic Aneurysm Presence Science: Article
Int J Cardiol Circulating soluble low-density lipoprotein receptor-related protein 1 (sLRP1) concentration is associated with hypercholesterolemia: A new potential biomarker for atherosclerosis PubMed: 26285183
International Journal of Cardiology Circulating levels of soluble low-density lipoprotein receptor-related protein 1 (sLRP1) as novel biomarker of epicardial adipose tissue pubmed:27543712
Journal of Cellular and Molecular Medicine Extracellular vesicles do not contribute to higher circulating levels of soluble LRP1 in idiopathic dilated cardiomyopathy doi:10.1111
Scientific Reports Soluble LRP1 is an independent biomarker of epicardial fat volume in patients with type 1 diabetes mellitus Pubmed:29348672
Atherosclerosis Soluble low-density lipoprotein receptor-related protein 1 as a biomarker of coronary risk: Predictive capacity and association with clinical events
Biomedical Reports Gender difference and genetic variance in lipoprotein receptor‑related protein 1 is associated with mortality
biorxiv. CMTM6 drives cisplatin resistance in OSCC by regulating AKT mediated Wnt signaling
JCI Insight CMTM6 drives cisplatin resistance by regulating Wnt signaling through ENO-1/AKT/GSK3¦Â axis 33434185
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPB010Mu02 Recombinant Low Density Lipoprotein Receptor Related Protein 1 (LRP1) Positive Control; Immunogen; SDS-PAGE; WB.
RPB010Mu01 Recombinant Low Density Lipoprotein Receptor Related Protein 1 (LRP1) Positive Control; Immunogen; SDS-PAGE; WB.
PAB010Mu02 Polyclonal Antibody to Low Density Lipoprotein Receptor Related Protein 1 (LRP1) WB; IHC; ICC; IP.
PAB010Mu01 Polyclonal Antibody to Low Density Lipoprotein Receptor Related Protein 1 (LRP1) WB; IHC; ICC; IP.
SEB010Mu ELISA Kit for Low Density Lipoprotein Receptor Related Protein 1 (LRP1) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB010Mu Multiplex Assay Kit for Low Density Lipoprotein Receptor Related Protein 1 (LRP1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.